Adamis Pharma (ADMP) Financials

$0.49

$-0.02 (-2.97%)

As on 09-Nov-2023 09:30EDT

Market cap

$7 Mln

Revenue (TTM)

$13 Mln

P/E Ratio

--

P/B Ratio

8.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	12.67	4.76	2.21	16.53	22.11	15.09
Cost of Revenue	4.63	6.19	6.87	14.89	15.48	9.80
Gross Profit	8.04	-1.43	-4.66	1.63	6.64	5.29
Operating Expenses	17.45	23.63	27.41	38.86	35.66	44.74
Operating Profit (EBIT)	-25.34	-25.06	-32.07	-37.23	-29.03	-39.46
Other Income	--	--	--	0.55	0.18	0.25
Profit before Tax	-19.07	-26.20	-34.60	-49.39	-29.30	-39.38
Provision for Tax	-7.00	0.00	0.00	0.00	0.01	-0.37
Profit after Tax (Net Income)	-11.56	-26.20	-34.60	-49.39	-29.31	-39.01
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-45.83	-49.39	-29.31	-39.01

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	-4,964.64	-0.81	25.88	3.50	36.04	46.69
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	459.58	0.34	1.19	7.44	1.59	0.11
Current Liabilities	13,462.47	11.40	11.22	19.93	10.21	11.55
Total Liabilities	22,419.88	10.93	38.30	30.87	47.84	58.36

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	1,085.35	1.66	3.09	18.34	33.96	32.57
Current Assets	7,872.06	9.27	35.20	12.52	13.88	25.78
Total Assets	16,829.47	10.93	38.30	30.87	47.84	58.36
Total Debt*	63.21	0.34	0.69	6.86	4.08	2.58
Net Current Assets	--	-2.12	23.98	-7.40	3.67	14.23

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-25.90	-37.79	-20.90	-19.89	-32.66
Cash Flow from Investing Activities	--	--	0.28	-0.95	-2.87	-3.54
Cash from Financing Activities	--	0.29	53.94	19.89	12.29	37.13
Net Cash Inflow / Outflow	--	--	--	-1.96	-10.46	0.94

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-4.84	-12.23	-16.24	-0.53	-33.18	-57.63
Cash EPS ($)	--	-11.54	-15.56	-0.49	-29.85	-53.05
Adjusted Book Value ($)	--	--	12.15	0.04	40.80	68.98
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-12.09	-17.73	-0.22	-22.52	-48.25
Free Cash Flow per Share ($)	--	-12.41	-18.30	-0.23	-25.76	-53.47

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-200.69	-187.38	-195.72	-65.57	-83.09
ROE (%)	--	-208.97	-235.53	-249.86	-70.85	-90.46
ROA (%)	-0.14	-106.44	-100.05	-125.50	-55.19	-71.08
EBIT Margin (%)	-118.92	-526.88	-1,451.97	-225.25	-131.27	-259.88
Net Margin (%)	-91.20	-550.86	-1,566.56	-289.24	-131.48	-254.41
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	722.57	1.15	-0.87	-0.25	0.47	0.15
EBIT Growth (%)	48.58	21.86	13.86	-28.25	25.96	-53.45
Net Profit Growth (%)	63.80	24.28	29.95	-68.53	24.87	-52.73
EPS Growth (%)	67.58	0.25	-29.85	0.98	0.42	-0.08
Book Value Growth (%)	-53,008.60	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-0.01	-0.04	-0.92	-0.02	-0.04
Price / Book Value	8.62	-0.45	0.05	13.02	0.02	0.03
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.78	0.02	0.69	-1.36	0.16	0.42
Close Price ($)	0.69	0.17	0.61	0.49	0.70	2.25
High Price ($)	8.28	0.85	2.34	1.51	3.29	5.10
Low Price ($)	0.05	0.12	0.49	0.27	0.48	2.01
Market Cap ($ Cr)	7.25	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	-0.42	0.03	1.96	0.11	0.06
Short term debt to equity ratio	-0.01	-0.42	0.01	1.39	0.07	0.06
Current Ratio	0.58	0.81	3.14	0.63	1.36	2.23
Quick Ratio	0.54	0.70	3.10	0.47	1.16	1.95
Interest Coverage	-5.54	-567.90	-4,823.19	-233.22	-235.51	-248.52

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	22.81	267.13	6.61	8.49	7.66
Asset Turnover	0.00	0.19	0.06	0.42	0.42	0.27
Receivable days	--	268.21	578.21	32.82	25.05	24.03
Inventory Days	--	48.92	93.93	63.48	63.00	95.13
Payable days	--	345.08	192.55	95.14	99.56	132.15
Cash Conversion Cycle	--	-27.95	479.58	1.16	-11.51	-12.99

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.